Cargando…
Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
Changes have been made to the AnaConDa device (Sedana Medical, Stockholm, Sweden), decreasing its size to reduce dead space and carbon dioxide (CO(2)) retention. However, this also involves a decrease in the surface area of the activated carbon filter. The CO(2) elimination and sevoflurane (SEV) ref...
Autores principales: | Marcos-Vidal, Jose Miguel, Merino, María, González, Rafael, García, Cristina, Rey, Saleta, Pérez, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222112/ https://www.ncbi.nlm.nih.gov/pubmed/30784010 http://dx.doi.org/10.1007/s10877-019-00285-0 |
Ejemplares similares
-
In vitro performance evaluation of AnaConDa(TM)-100 and AnaConDa(TM)-50 compared to a circle breathing system for control and consumption of volatile anaesthetics
por: Bellgardt, Martin, et al.
Publicado: (2020) -
Sevoflurane Sedation with AnaConDa-S Device for a Child Undergoing Extracorporeal Membrane Oxygenation
por: Soreze, Yohan, et al.
Publicado: (2020) -
A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa(®) device
por: Misra, Satyajeet, et al.
Publicado: (2012) -
AnaConDa™ and Mirus™ for intensive care sedation, 24 h desflurane versus isoflurane in one patient
por: Bomberg, Hagen, et al.
Publicado: (2016) -
AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Corona Virus Disease 2019 Pandemic
por: Labaste, François, et al.
Publicado: (2021)